Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NANO

Nanobiotix (NANO)

Nanobiotix
Date:
Sort by:
 Showing the most relevant articles for your search:EU:NANO
DateTimeSourceHeadlineSymbolCompany
07/10/20236:37PMDow Jones NewsADRs End Mostly Lower, Nanobiotix and Taiwan Semiconductor Manufacturing Trade ActivelyEU:NANONanobiotix
07/10/20237:37AMDow Jones NewsECHO BOURSE: Nanobiotix bondit de 51% après un accord de licence avec JanssenEU:NANONanobiotix
07/10/20236:57AMDow Jones NewsNanobiotix Shares Soar on Licensing Deal With J&J UnitEU:NANONanobiotix
05/05/20231:11PMDow Jones NewsECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envoleEU:NANONanobiotix
05/05/20231:06PMDow Jones NewsECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envoleEU:NANONanobiotix
07/09/20192:45PMGlobeNewswire Inc.Nanobiotix announces publication of phase III Soft Tissue Sarcoma data for first-in-class NBTXR3 in the Lancet OncologyEU:NANONanobiotix
07/01/20192:00AMGlobeNewswire Inc.Nanobiotix announces new organizational structure as the company enters its next stage after first european market approvalEU:NANONanobiotix
06/04/20192:00AMGlobeNewswire Inc.NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVALEU:NANONanobiotix
05/28/20191:00AMGlobeNewswire Inc.Nanobiotix announces the launch of curadigm : a new nanotechnology platform for healthcareEU:NANONanobiotix
04/04/201912:31PMGlobeNewswire Inc.Nanobiotix Announces First Ever Radioenhancer to Receive European Market ApprovalEU:NANONanobiotix
04/02/201912:56PMGlobeNewswire Inc.Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pr...EU:NANONanobiotix
03/26/20193:00AMGlobeNewswire Inc.Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedbackEU:NANONanobiotix
03/15/20191:40PMGlobeNewswire Inc.Nanobiotix 2018 Annual ResultsEU:NANONanobiotix
11/15/20187:00AMGlobeNewswire Inc.Nanobiotix revenues for the 3rd quarter of 2018EU:NANONanobiotix
10/19/20188:05AMGlobeNewswire Inc.NANOBIOTIX: Positive phase II/III results for NBTXR3 in Soft Tissue Sarcoma presented at ESMOEU:NANONanobiotix
10/15/201810:13PMGlobeNewswire Inc.Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment BankEU:NANONanobiotix
09/25/201810:00PMGlobeNewswire Inc.Nanobiotix to present positive results from its phase II/III clinical trial of NBTXR3 in patients with Soft Tissue Sarcoma (S...EU:NANONanobiotix
09/19/201810:04PMGlobeNewswire Inc.Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018EU:NANONanobiotix
09/04/201812:20PMGlobeNewswire Inc.NANOBIOTIX half year results for the six months ended June 30, 2018EU:NANONanobiotix
07/26/201812:32PMGlobeNewswire Inc.NANOBIOTIX signs a 40 M€ non-dilutive financing agreement with the European Investment BankEU:NANONanobiotix
06/22/20188:29AMDow Jones NewsNanobiotix offre un succès bienvenu pour relancer les biotechs tricolores - DJ PlusEU:NANONanobiotix
06/21/20181:41PMGlobeNewswire Inc.NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3EU:NANONanobiotix
06/06/20189:55AMGlobeNewswire Inc.NANOBIOTIX' Management statement on recent share price variationEU:NANONanobiotix
05/14/20182:57AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
05/03/20181:35PMGlobeNewswire Inc.Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathwa...EU:NANONanobiotix
04/17/20182:01PMGlobeNewswire Inc.AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING path...EU:NANONanobiotix
04/11/20183:01AMCercle FinanceNanobiotix: projet de recherche avec le MD AndersonEU:NANONanobiotix
04/10/20182:42PMGlobeNewswire Inc.NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-...EU:NANONanobiotix
03/30/201810:03AMGlobeNewswire Inc.NANOBIOTIX : Nanobiotix 2017 Annual ResultsEU:NANONanobiotix
03/26/20183:12AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
 Showing the most relevant articles for your search:EU:NANO